Olema Pharmaceuticals Newsroom

LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $29

Moomoo NewsOct 24 19:36 ET

Capital One Financial Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsOct 24 08:31 ET

Promising Potential of Olema Pharmaceuticals' Palazestrant and KAT6 Inhibitor Fuels Buy Rating

TipRanksOct 24 07:57 ET

Olema Pharmaceuticals Analyst Ratings

BenzingaOct 24 05:44 ET

H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsOct 23 12:31 ET

Buy Rating for Olema Pharmaceuticals: Promising Preclinical Data and Strategic Pipeline Synergy

TipRanksOct 23 12:09 ET

Goldman Sachs Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Raises Target Price to $27

Moomoo NewsSep 10 12:31 ET

Olema Pharmaceuticals Analyst Ratings

BenzingaAug 8 12:24 ET

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow JonesAug 7 16:45 ET

Olema Pharmaceuticals Analyst Ratings

BenzingaAug 7 13:59 ET

Oppenheimer Reiterates Outperform on Olema Pharmaceuticals, Maintains $30 Price Target

BenzingaAug 7 13:59 ET

Buy Rating Reaffirmed for Olema Pharmaceuticals Amid Promising Breast Cancer Treatment Advances and Strong Financials

TipRanksAug 7 08:38 ET

Buy Rating Affirmed for Olema Pharmaceuticals Amidst Promising Clinical Developments and Strategic Collaborations

TipRanksAug 6 18:47 ET

Olema Pharmaceuticals Analyst Ratings

BenzingaJun 4 07:03 ET

Buy Rating Affirmed for Olema Pharmaceuticals on Strong Clinical Trial Data for Palazestrant and Ribociclib Combination

TipRanksMay 16 06:11 ET

Buy Rating Justified by Promising Efficacy and Safety Profile of Olema Pharmaceuticals' Drug Combination in Clinical Studies

TipRanksMay 15 15:50 ET

Olema Pharmaceuticals Analyst Ratings

BenzingaMay 15 14:00 ET

Promising Clinical Trial Results Bolster Buy Rating for Olema Pharmaceuticals

TipRanksMay 15 11:50 ET

Olema Pharmaceuticals Analyst Ratings

BenzingaMay 9 15:32 ET

Buy Rating on Olema Pharmaceuticals Amid Promising Clinical Trials and Strong Financial Position

TipRanksMay 9 07:16 ET